Abstract
Psychological factors have long been suspected to influence lung function in asthma. While earlier experimental research has demonstrated the susceptibility of the airways to suggestion, only recent studies have investigated the impact of various emotional states and stressful challenge on the airways in health and asthma. We reviewed studies from the last 15 years that have used experimental emotion and stress induction techniques or longitudinal diary observations to explore these influences. Findings suggest that unpleasant emotional states are associated with a decline in lung function in health and asthma. Changes are usually small on average, but usually reach clinical significance in a subset of patients. Pleasant emotional states are also sometimes associated with a lung function decline, suggesting a susceptibility of the airways to arousal in general. From longitudinal studies, more evidence for effects of both pleasant and unpleasant states is available, but also highly idiosyncratic associations between mood, stress, and lung functions were observed. While initial findings indicate the importance of specific autonomic, ventilatory, and immunological pathways for emotion-induced lung function changes, more research is needed on these underlying mechanisms.
Keywords: asthma, stress, emotion, airways, lung function, respiratory resistance
Current Respiratory Medicine Reviews
Title: Effects of Emotion and Stress on Lung Function in Health and Asthma
Volume: 1 Issue: 2
Author(s): Thomas Ritz and Antje Kullowatz
Affiliation:
Keywords: asthma, stress, emotion, airways, lung function, respiratory resistance
Abstract: Psychological factors have long been suspected to influence lung function in asthma. While earlier experimental research has demonstrated the susceptibility of the airways to suggestion, only recent studies have investigated the impact of various emotional states and stressful challenge on the airways in health and asthma. We reviewed studies from the last 15 years that have used experimental emotion and stress induction techniques or longitudinal diary observations to explore these influences. Findings suggest that unpleasant emotional states are associated with a decline in lung function in health and asthma. Changes are usually small on average, but usually reach clinical significance in a subset of patients. Pleasant emotional states are also sometimes associated with a lung function decline, suggesting a susceptibility of the airways to arousal in general. From longitudinal studies, more evidence for effects of both pleasant and unpleasant states is available, but also highly idiosyncratic associations between mood, stress, and lung functions were observed. While initial findings indicate the importance of specific autonomic, ventilatory, and immunological pathways for emotion-induced lung function changes, more research is needed on these underlying mechanisms.
Export Options
About this article
Cite this article as:
Ritz Thomas and Kullowatz Antje, Effects of Emotion and Stress on Lung Function in Health and Asthma, Current Respiratory Medicine Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573398054022993
DOI https://dx.doi.org/10.2174/1573398054022993 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Rationally Designed Multitarget Agents Against Inflammation and Pain
Current Medicinal Chemistry STAT3 as a Therapeutic Target for Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry The Regulation of FoxP3-Expressing Regulatory T Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design New Insight in LPS Antagonist
Mini-Reviews in Medicinal Chemistry Targeting IL-17 and IL-23 in Immune Mediated Renal Disease
Current Medicinal Chemistry Natural Therapies of the Inflammatory Bowel Disease: The Case of Rutin and its Aglycone, Quercetin
Mini-Reviews in Medicinal Chemistry Bronchial Asthma, Chronic Obstructive Pulmonary Disease and NF-κB
Current Medicinal Chemistry Evaluation and Management of Severe Asthma
Current Medicinal Chemistry Anti-IgE Monoclonal Antibody (Omalizumab) in the Treatment of Atopic Asthma and Allergic Respiratory Diseases
Current Drug Targets - Inflammation & Allergy Adjudin - A Male Contraceptive with Other Biological Activities
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Rational Design and Development of Colon-Specific Prodrugs
Current Topics in Medicinal Chemistry Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective
Current Pharmaceutical Design The HLA Region and Autoimmune Disease: Associations and Mechanisms of Action
Current Genomics Recent Advances in the Characterization of Genetic Factors Involved in Human Susceptibility to Infection by Schistosomiasis
Current Genomics Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Donkeys and Goats Milk Consumption and Benefits to Human Health with Special Reference to the Inflammatory Status
Current Pharmaceutical Design Genomics of Chronic Obstructive Pulmonary Disease (COPD); Exploring the SNPs of Protease-Antiprotease Pathway
Current Genomics Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors
Current Pharmaceutical Design Carbon Nanotubes – Curse or Blessing
Current Medicinal Chemistry